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Abstract

Background There has been growing interest regarding the impact of telemonitoring and its ability to reduce
the increasing burden of chronic diseases, including chronic cardiovascular disease (CVD), on healthcare
systems. A number of randomised trials have been undertaken internationally and synthesised into various
systematic reviews to establish an evidence base for this model of care. This study sought to synthesise and
critically evaluate this large body of evidence to inform clinicians, researchers and policy makers. Methods A
systematic review of systematic reviews investigating the impact of telemonitoring interventions in the
primary care management of CVD was conducted. Reviews were included if they explored primary care based
telemonitoring in either CVD, heart failure or hypertension, were reported in the English language and were
published between 2000 and 2013. Data was extracted by one reviewer and checked by a second reviewer
using a standardised form. Two assessors then rated the quality of each review using the Overview Quality
Assessment Questionnaire (OQAQ). Results Of the 13 included reviews, four focused on telemonitoring
interventions in hypertension or CVD management and the remaining 9 reviews investigated telemonitoring
in HF management. Seven reviews scored a five or above on the OQAQ evidencing good quality reviews.
Findings suggest that telemonitoring can contribute to significant reductions in blood pressure, decreased allcause and HF related hospitalisations, reduced all-cause mortality and improved quality of life.
Telemonitoring was also demonstrated to reduce health care costs and appears acceptable to patients.
Conclusion Telemonitoring has the potential to enhance primary care management of CVD by improving
patient outcomes and reducing health costs. However, further research needs to explore the specific elements
of telemonitoring interventions to determine the relative value of the various elements. Additionally, the ways
in which telemonitoring care improves health outcomes needs to be further explored to understand the nature
of these interventions.
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Abstract
Background: There has been growing interest regarding the impact of telemonitoring and its ability to reduce the
increasing burden of chronic diseases, including chronic cardiovascular disease (CVD), on healthcare systems. A
number of randomised trials have been undertaken internationally and synthesised into various systematic reviews
to establish an evidence base for this model of care. This study sought to synthesise and critically evaluate this
large body of evidence to inform clinicians, researchers and policy makers.
Methods: A systematic review of systematic reviews investigating the impact of telemonitoring interventions in the
primary care management of CVD was conducted. Reviews were included if they explored primary care based
telemonitoring in either CVD, heart failure or hypertension, were reported in the English language and were
published between 2000 and 2013. Data was extracted by one reviewer and checked by a second reviewer using a
standardised form. Two assessors then rated the quality of each review using the Overview Quality Assessment
Questionnaire (OQAQ).
Results: Of the 13 included reviews, four focused on telemonitoring interventions in hypertension or CVD
management and the remaining 9 reviews investigated telemonitoring in HF management. Seven reviews scored a
five or above on the OQAQ evidencing good quality reviews. Findings suggest that telemonitoring can contribute
to significant reductions in blood pressure, decreased all-cause and HF related hospitalisations, reduced all-cause
mortality and improved quality of life. Telemonitoring was also demonstrated to reduce health care costs and
appears acceptable to patients.
Conclusion: Telemonitoring has the potential to enhance primary care management of CVD by improving patient
outcomes and reducing health costs. However, further research needs to explore the specific elements of
telemonitoring interventions to determine the relative value of the various elements. Additionally, the ways in
which telemonitoring care improves health outcomes needs to be further explored to understand the nature of
these interventions.
Keywords: Systematic review, Telemonitoring, Heart failure, Hypertension, Primary care
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Background
The growing burden of the group of diseases that comprise
cardiovascular disease (CVD) on national healthcare systems is well recognised amongst healthcare professionals
internationally. Despite a trend towards decreasing mortality, CVD remains the major cause of death worldwide [1].
In Australia, CVD accounts for a greater proportion of
deaths than any other disease group, and accounts for the
highest proportion of direct health care expenditure [2].
Improved acute care, advanced intervention techniques,
early diagnostic procedures, and worldwide demographic
ageing have resulted in an increasing number of patients
living with chronic CVD [3,4]. As a result, chronic heart
failure (HF) is becoming an increasing health issue [5]. Almost half the individuals admitted to hospital for HF are
re-admitted within 6 months [6,7]. These frequent hospital
re-admissions contribute significantly to the high costs of
HF management [6,7]. Up to 70% of HF cases, are preceded
by hypertension [5]. Implementation of evidence based
hypertension management has the potential to reduce the
prevalence of HF and, subsequently, reduce HF burden.
Given the interrelationship and progressive nature of cardiac disease in primary care, there are advantages in considering the impact of management strategies across the
disease silos.
The increasing burden associated with CVD necessitates the investigation of innovative models to
provide evidence-based care to promote early identification of exacerbations and early intervention to minimise their severity. Among the available models is
telemonitoring, which consists of remote monitoring
of patients to enable clinicians to intervene when
there is evidence of clinical deterioration in an
attempt to avoid hospitalisation [8]. Telemonitoring
moves patient care out of a clinical setting into
the patient’s home by utilising telecommunications
technologies such as the Internet, telephone, or videoconferencing to transmit physiological data and information about current symptoms from the patient
to health care professionals [8]. Shifting the burden of
care to the patient’s home also facilitates supported
self-care, giving the patient enhanced autonomy and
control of their health care [8]. Telemonitoring programs can be flexible, individually tailored, and have
the potential to provide access to specialist care for a
larger number of patients across a much greater
geography when compared to usual care [8-10].
Currently the literature reports multiple systematic reviews investigating the effectiveness of telemonitoring in
both HF and its antecedent, hypertension. Given the large
amount of literature available, a systematic review of reviews was conducted to synthesise and critically evaluate
this current Level 1 evidence around the use of telemonitoring in the primary care setting.
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Methods
This review was conducted using the Preferred Reporting
Items of Systematic Reviews Meta-Analyses (PRISMA)
guidelines [11]. A systematic review design was selected to
limit any bias in the selection and reporting of evidence.
Search strategy

A comprehensive and systematic search was undertaken
using CINAHL, MEDLINE and the Cochrane Library
electronic databases. The search strategy included the
Medical Subject Headings (MeSH) terms; telehealth,
telemedicine, heart failure, hypertension, cardiovascular
disease and systematic review. As a relatively new form
of technology, reviews were retrieved if they were published between 2000 and 2013. Secondary searching of
the reference lists of retrieved papers and of the Internet
via the Google scholar search engine was undertaken to
identify any additional reviews that met the inclusion
criteria.
Selection procedures

Papers were retrieved based on whether the title and abstract or, if required, the full manuscript met the inclusion
criteria for this review. Papers identified through the search
were assessed based on the inclusion and exclusion criteria
by two independent reviewers (RP and EH). Where there
was discrepancy, the reviewers discussed the issues and
reached consensus.
Inclusion criteria

Systematic reviews were included if they met the following inclusion criteria. Firstly, the paper needed to report
a systematic review or meta-analysis of original intervention studies. Reviews that did not meet the definition of
a systematic review or meta-analysis, or were expert
commentaries were not included [8]. Secondly, included
reviews needed to explore the impact of telemonitoring
on the health outcomes of adults with known CVD as
distinct from those with other chronic diseases. An a
priori decision was made to not include studies with
paediatric samples. Thirdly, given the focus on telemonitoring as distinct from home monitoring, reviews were
excluded if there was no evidence that home based measures were transmitted to a healthcare provider. Finally,
due to resource constraints and ease of access, reviews
that were published in any language other than English,
or reviews that were unpublished were excluded from
the analysis.
Data extraction

Two authors (RP and EH) developed a standardised form
for extracting data and relevant information from the 13 included reviews. Whilst developed specifically for this review, the form was based on tools used in other systematic
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reviews and systematic reviews of reviews [12,13]. The form
contained 10 categories regarding the characteristics and
results of the included reviews. All data were initially extracted by one author (RP), this extraction was then
checked by a second author (EH) for accuracy. Where differences were identified, the authors discussed issues and
reached a consensus decision.
Methodological quality

A two-stage process was undertaken to evaluate both the
type of evidence contained in each included review, and the
quality of the review process used. In the first stage of this
process, the level of evidence was graded using the National
Health & Medical Research Council (NHMRC) hierarchy
(Table 1). Whilst systematic reviews of randomised controlled trials are considered the highest level of evidence on
this hierarchy, other reviews are ranked only as high as
their included studies [14].
In the second stage of this process, the quality of included systematic reviews and meta-analyses were
assessed using the component and total scores from the
Overview Quality Assessment Questionnaire (OQAQ).
The OQAQ has been previously validated as a measure
of quality in research reviews [15,16]. Two reviewers independently scored each paper using OQAQ (RP and
SM) and any disparities were discussed with a third reviewer (EH) until consensus was reached.

Results
Ninety-nine papers were identified by the search strategy
and assessed against the review inclusion criteria. All reviewers agreed that 13 papers met the inclusion criteria for
the review. Papers were excluded if they did not distinguish
individuals with CVD from those in other disease groups,
the intervention did not involve information transmission
between the consumer and health provider or did not report a formal systematic review (references to these papers
can be provided on request). The flowchart in Figure 1 outlines the process for selecting included papers.
Of the 13 included reviews, nine were graded as Level 1
on the NHMRC Hierarchy [8,10,17-23]. The remaining reviews included a combination of RCTs, observational, descriptive, case series and/or non-randomised controlled
studies, therefore, were considered to be Level II to IV
Table 1 NHMRC hierarchy of evidence [14]
Level of
evidence

Descriptor

I

Systematic review of randomised controlled trials

II

Randomised controlled trial

III

Pseudo-randomised controlled trial, comparative study
with or without concurrent controls

IV

Case series with either post-test or pre-test/post-test
outcomes
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evidence [24-27]. Seven reviews [8,10,17,18,23,26,28] scored
five or above on OQAQ, indicating minor or no methodological flaws [15] (Table 2). Reviews that failed to score
above a five predominantly did so due to the poor assessment of validity in primary studies and/or the authors failing to use a validated quality scoring system. The quality
features of included systematic reviews are presented in
Table 2.
As can be seen in Tables 3 and 4, 9 reviews investigated telemonitoring for heart failure [8,10,21-27], three
focused on telemonitoring interventions for hypertension [17,19,20] and a single review looked at risk factor
reduction in CVD [18]. The number of studies synthesised in the included reviews varied between 9 [20,21]
and 56 [25] studies. Whilst the number of included participants was not accurately reported in two reviews
[24,26], in the remaining reviews the number of participants ranged from 2,401 to 9,946 [8,10,17-22,25,27,28].
Definitions of telemonitoring varied, with some reviews of hypertension management only citing studies
that used telemonitoring to transmit physiological data
[20,22] and other reviews included studies of telemonitoring combined with additional support, such as counselling, and/or education [8,10,17-19,21,24-28]. In some
reviews it was possible to compare outcomes between
various types of interventions [8,21,25], whilst in others
various interventions were combined in the analysis
[23]. This variation is a reflection of the current state of
the literature and the significant variety of operational
definitions of telemonitoring between studies included
in the reviews.
A diverse range of outcomes was measured across the
reviews. Those reviews which investigated hypertension
primarily used blood pressure and medication use as
outcomes (Table 3), whilst those investigating HF used a
combination of outcomes including, mortality, hospital
admissions, quality of life, cost, acceptability (Table 4).
All reviews reported benefits associated with telemonitoring, however the significance of the identified benefits
differed between studies and reviews. No review reported negative effects of telemonitoring or harm to patients. All reviews noted significant variance between
included studies with four reviews citing statistically significant heterogeneity [8,18,19]. It is essential that this
be considered in the interpretation of these data.
Synthesis of reviews of hypertension & CVD management

Table 3 provides a summary of the four included reviews
that focused on telemonitoring in hypertension and
CVD management.
Blood pressure

The four reviews which investigated hypertension and
CVD management all used blood pressure as an outcome
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Figure 1 Process of review selection.

measure [17-20]. The operational definition of blood pressure differed across reviews with all reviews reporting systolic blood pressure [17-20], three reporting diastolic
pressure [17,19,20], one review reporting mean arterial
pressure [17] and another reporting blood pressure normalisation [19]. All reviews reported significant reductions in
blood pressure with the various interventions (Table 3).
Given the concomitant changes in extraneous variables
such as medication use and lifestyle risk factors that occurred around the interventions, it is difficult to ascertain
which specific aspects of the intervention led to the improvements in blood pressure seen within these reviews
and included studies.
Medication use

Three reviews which investigated hypertension and CVD
management reported medication use as an outcome measure [17,19,20]. There was some variation in finding of
medication use between reviews. Agarwal et al. [17] reported that 10 studies demonstrated reduced medication
use (RR 2.02, 95% CI 1.32 to 3.11) and 12 studies reported
no greater increase in medication (RR 0.94, 95% CI 0.75 to
1.19). In contrast, Omboni & Guarda [19] reported five
studies that demonstrated increased use of antihypertensive
medications (WMD +0.22, 95% CI: +0.02, +0.43). It should
be noted that this increase in antihypertensive use may have
been a positive finding if patients had been sub-optimally
medicated and were now receiving best practice
pharmacotherapy.
In their review, Verberk et al. [20] compared the
outcomes of those who had their antihypertensive
treatment modified and those who did not have
modified treatment during the study in both the
intervention and treatment groups. This comparison
demonstrated that treatment modification was associated

with significantly lower systolic BP compared to nonmodification (5.1 mmHg ± 2.9 mmHg lower).
Synthesis of reviews of heart failure management

Table 4 provides a summary of the nine included reviews
that focused on telemonitoring in HF management.
Hospital admission

Eight of the reviews of HF management used hospitalisation as an outcome measure [8,10,21-26]. All these reviews
reported that telemonitoring was associated with reduced
hospitalisations [8,10,21-27]. The reduction in hospitalisation was reportedly as high as 50% in one review [21].
However, three reviews reported included studies that did
not demonstrate a statistically significant reduction in
hospitalisation rates [10,21,22]. Indeed in their review,
Giamouzis et al. [22] identified four included studies in
which the telemonitoring group had more rehospitalisation’s
than the usual care group, although these findings were
either non-significant or the significance was not reported.
In terms of HF related hospitalisations, Inglis et al. [8] reported that both telemonitoring and structured telephone
support reduced the number of patients having a HF related admission to hospital (structured telephone support
RR 0.77, 95% CI 0.68 to 0.87, P < 0.0001 and telemonitoring
RR 0.79, 95% CI 0.67 to 0.94, P = 0.008). Similarly,
Chaudhry et al. [21] found that both video conferencing
and regular nurse phone calls reduced 6-month HF related
admissions to hospital compared to usual care. However,
there were no between group differences between video
conferencing and regular nurse support.
Length of stay

Length of stay (LOS) was reported as an outcome in five
included reviews [8,23-26]. However, in three of these

Quality criteria

Clark
Neubeck
Inglis
Martínez Agarwal
Klersy
Chaudhry Giamouzis Seto Verberk
Louis
Maric
Omboni
et al. [10] et al. [18] et al. [8] et al. [26] et al. [17] et al. [23] et al. [21] et al. [22] [27] et al. [20] et al. [24] et al. [25] et al. [19]

Search methods used to find evidence stated

3

1

3

3

3

3

3

2

3

3

3

2

3

Search for evidence reasonably
comprehensive

3

3

3

2

2

2

2

2

2

2

2

2

2

Criteria used for deciding which studies to
include reported

3

3

3

2

3

2

2

3

3

3

2

3

3

Bias in the selection of studies avoided

3

3

3

2

3

3

2

3

3

3

2

3

3

Criteria used for assessing validity of
included studies reported

3

3

3

3

2

2

2

1

1

1

1

1

1

Validity of included studies assessed
appropriately

3

3

2

3

2

2

2

1

1

1

1

1

1

Methods used to combine the findings of
studies reported

3

3

3

3

3

3

3

2

3

3

2

2

3

Findings of studies combined appropriately

3

3

3

3

3

3

3

2

3

3

2

2

2

Conclusions made by authors supported by
analysis

3

3

3

3

3

3

2

3

3

2

3

2

3

Overall Quality Score

7

7

6

6

5

5

4

3

3

3

3

2

2
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Table 2 OQAQ Scores for the methodological quality of included reviews
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Citation

NHMRC Included
Total
Participants
level of studies participants condition
evidence

Inclusion
criteria

Intervention

Agarwal
et al. [17]

I

37

9446

Hypertension • Published Home BP monitoring
between
compared to a control
1966-2010 group.

Neubeck
et al. [18]

I

11

3145

Coronary
Heart
Disease

• English
language
• Published
between
1990-2008

Intervention involved
home monitoring with
50% patient provider
contact for risk factor
modification and advice/
counselling for CHD
patients
• Telephone based
telemonitoring – 9
studies
• Internet based
telemonitoring – 2
studies

Omboni
et al. [19]

I

12

5044

Hypertension • English
language
• Published
between
inception
- 2010

Home BP monitoring
with data being
automatically transferred
compared to control
group.

Outcomes

Results

Conclusion

Compared with clinic based
measurements, home based BP
monitoring;
• Improved systolic BP (SMD −2.63
mmHg, 95% CI −4.24 to −1.02; 22
studies)
• Improved diastolic BP (SMD 1.68 mmHg, 95% CI −2.58
to −0.79 mmHg; 22 studies)
• Improved mean arterial pressure
(SMD −4.0 mmHg, 95% CI −6.22
to −1.79 mmHg; 3 studies)
• Reduced medication use (RR 2.02,
95% CI 1.32 to 3.11; 10 studies)
• Reduced therapeutic inertia (RR 0.82,
95% CI 0.68 to 0.99; 15 studies)
• Led to no greater increase in
medication (RR 0.94, 95% CI 0.75
to 1.19; 12 studies)

• Compared with clinic BP
monitoring alone, home BP
monitoring had the potential to
overcome therapeutic inertia
[no change in medication].
• Lead to a small but significant
reduction in systolic and
diastolic BP.
• Hypertension management
with home BP monitoring can
be enhanced when used with
telemonitoring.

• All-cause mortality
• Modifiable risk factors including cholesterol (and
associated measures), BP, BMI,
Smoking Status,
Physical Activity
• Quality of life
• Cost

Compared to the control group the
evidence suggests that the intervention
group had;
• Reduced total cholesterol (WMD
0.37 mmol/L, 95% CI: 0.19 to 0.56,
9 studies)
• Reduced low-density lipoprotein chol
esterol (WMD 0.41 mmol/L, 95% CI:
0.36 to 0.56, 4 studies)
• Reduced systolic blood pressure
(WMD 4.69 mmHg, 95% CI 2.91 to 6.47,
7 studies)
• Reduced risk of smoking (RR 0.83,
95% CI: 0.70 to 0.99, 7 studies)

• Telemonitoring interventions
provided effective risk factor
reduction and secondary
prevention in patients with CHD.
• Telemonitoring could increase
the uptake of formal secondary
prevention by those who do not
access cardiac rehabilitation, and
narrow the current gap between
evidence and practice.

• Change in BP
(diastolic, systolic
and normalisation)
• Medication

Compared to controls the overall
effect of home BP monitoring was;
• Improved office systolic BP (5.64 mm
Hg, 95% CI: 7.92 to 3.36 mm Hg,
11 studies)
• Improved office diastolic BP (2.78
mm Hg, 95% CI: 3.93 to 1.62 mm
Hg, 11studies)
• Improved ambulatory systolic BP
(2.28 mm Hg, 95% CI: 4.32
to 0.24 mm Hg; 3 studies)
• Improvement in BP control (RR
1.31, 95% CI: 1.06 1.62, 5 studies)

• Home blood pressure
telemonitoring may represent a
useful tool to improve blood
pressure control but welldesigned large-scale trials are still
needed to demonstrate its clinical
usefulness.
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• BP - diastolic,
systolic and mean
arterial
• Medication use
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Table 3 Summary table of included reviews - hypertension

Verberk
et al. [20]

I

9

2662

Hypertension • English
language
• No
restriction
on dates
reported

Home BP transmitted via
telephone, internet,
modem or mail.

• BP - diastolic,
systolic
• Medication

• Increased use of antihypertensive
medications (WMD +0.22, 95%
CI: +0.02, +0.43, 5 studies)
Compared with usual care, home
based BP monitoring;
• Reduced systolic BP (5.19 mmHg, 95%
CI 2.31 to 8.07; 9 studies)
• Reduced diastolic BP (2.11 mmHg,
95% CI 0.52 to 3.69; 9 studies)
• There was no significant difference
between groups in the number of
patients that reached their target blood
pressure (3 studies)

• Telecare led to a greater
decrease in systolic and diastolic
blood pressure than usual care.
For systolic blood pressure, this
decrease was greater in trials
without treatment modification.
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Table 3 Summary table of included reviews - hypertension (Continued)
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Citation

NHMRC
level of
evidence

Chaudhry
et al. [21]

I

Clark et al.
[10]

I

Included
Total
Inclusion criteria
studies participants
9

3582

• English language
• Published between
1966-2006

14

4264

• English language
• Published between
2002-2006

Outcomes

Results

Nurse-led telephone symptom
monitoring (no meta
analysis) – 5 studies
Automated monitoring of
signs & symptoms – 1 study
Automated physiological
monitoring – 1 study
Comparisons of two or
more methods of
telemonitoring
(no meta-analysis) – 2 studies

• All cause and
HF mortality
• All cause and H
F admissions
• Cost

• Reduced all-cause hospitalisation (47%) (1 study)
• Reduced HF hospitalisations (2 studies) (20-50%
reduction)
• No significant difference in HF hospitalisations
(2 studies)
• Reduced emergency room visits (95% CI 0.36-0.80)
(1 study)
• Reduced mortality (1 study)
• Reduced health care costs ($1000 less per patient)
(1 study)
• No significant difference in all-cause hospitalisations
(1 study)
• Reduced mortality (56% - 95% CI 0.22-0.85) (1 study)
• Reduced HF hospitalisations (1 study) (40% - 95%
CI 0.45-0.82)
• Reduced health care costs ($276705 less 6-month
cumulative readmission charges in the intervention
group) (1 study)
• Both physiologic monitoring and regular nurse
telephone calls showed improved mortality and
hospitalisation rates compared to usual care
(1 study).
• No between group differences in mortality and
hospitalisation rates between physiologic monitoring
and regular nurse telephone calls (12.7% vs 15.9%)
(1 study).
• Both video conferencing and nursing support by
telephone showed reduced 6-month HF readmission
charges compared to usual care (1 study).
• No between group differences in 6-month HF
readmission charges were seen between video
conferencing and nursing support by telephone
(1 study).

Telemonitoring –
4 studies
Structured telephone
support – 9 studies
Telemonitoring and structured
telephone support – 1 study

• All-cause admissions
• HF admissions
• Quality of life
• Acceptability
• Cost
• All-cause mortality

• Both interventions were associated with a
statistically significant 20% reduction in all-cause
mortality (RR 0.80, 95% CI: 0.69 to 0.92; 14 studies)
• A decrease in all-cause mortality was more
pronounced with telemonitoring (RR 0.62, 95% CI: 0.45
to 0.85; 4 studies) than with structured telephone
support (RR 0.85, 95% CI: 0.72 to 1.01; 9 studies)
• HF related hospitalisation was significantly reduced
by 20% through remote monitoring programmes
(RR 0.79, 95% CI 11%-31%).
• None of the 8 studies that reported all cause
admission to hospital reported a statistically
significant result. The pooled estimates also did not
show significant benefit.
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Purcell et al. BMC Family Practice 2014, 15:43
http://www.biomedcentral.com/1471-2296/15/43

Table 4 Summary table of included reviews – heart failure

• 3/6 trials that investigated quality of life reported a
significant and substantial improvement.
• 3/4 trials of structured telephone support reported
lower healthcare costs.
• 4 trials reported acceptability of the intervention to
patients.
I

12

3,877

• English language
• Published between
1991 and November
2011
• Follow-up of at least
6 months
• At least 1 device to
measure and transmit
physiological data

Intervention involved recording
physiological data by portable devices, and
transmitting data remotely to a server.

• CVD related
mortality
• All-cause mortality
• Hospitalisation/
Readmissions
• Cost

Compared to controls the telemonitoring groups
had:
• Reduced hospitalisation rates that reached
statistical significance (3 studies)
• Reduced hospitalisation rates without reaching
statistical significance (4 studies).
• Statistically significant reduced all-cause mortality
(3 studies).
• Fewer reported deaths, however these results were
not statistically significant (5 studies)
• Evidence for costs associated with telemonitoring
were mixed with two studies finding cost reductions
and one study finding increased costs.
• In four studies there were more re-hospitalisations
in telemonitoring groups compared to usual care
groups, but these findings were either not statistically
significant or significance was not reported.

Inglis et al.
[8]

I

25

8323

• Published between
1999 – 2008

Telemonitoring (transfer of daily data) – 11
studies
Structured Telephone support – 16 studies
Both interventions – 2 studies

• HF and
all-cause
admissions
• Quality of life
• Acceptability
• Cost
• All-cause mortality
• Length of stay

• Telemonitoring reduced all-cause mortality (RR 0.66,
95% CI: 0.54–0.81; 11 studies)
• Structured telephone support showed a nonsignificant trend towards reduced all-cause mortality
(RR 0.88 95% CI: 0.76– 1.01; 15 studies)
• Both telemonitoring (RR 0.79, 95% CI: 0.67–0.94;
4 studies), and structured telephone support (RR 0.77,
95% CI 0.68–0.87; 13 studies) reduced chronic heart
failure related hospitalisations
• Both interventions improved quality of life, reduced
costs, and were acceptable to patients
• 1/6 studies reported a statistically significant
reduction in length of stay, with a further 2 studies
reporting a non-significant reduction

Klersy
et al. [23]

I

21

5715

• Published before
September 2009

Either structured telephone monitoring or
technology assisted monitoring –
collectively referred to as remote patient
monitoring.

• Hospitalisations
• LOS
• Cost
• Quality of life

• Remote patient monitoring was associated with
significantly fewer hospitalizations for HF (incidence
rate ratio: 0.77, 95% CI 0.65–0.91, P < 0.001) (18 studies)
• Remote patient monitoring was associated with
significantly fewer hospitalizations for any cause
(incidence rate ratio: 0.87, 95% CI: 0.79–0.96,
P = 0.003) (18 studies)
• LOS was not different between remote patient
monitoring and usual care for either HF
hospitalisations (95% CI 20.12–0.13, P = 0.88) or
all-cause hospitalisation (95% CI 20.18–0.02, P = 0.83)
(12 studies).
• RPM reduced costs between 300 to 1000 euros

• RCTS reporting
hospitalisation and
LOS data
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Table 4 Summary table of included reviews – heart failure (Continued)

• RPM was associated with a gain of 0.06 qualityadjusted life years – 0.02 due to reduced mortality
and 0.04 due to reduced hospitalisations
Louis et al.
[24]

III1

Maric et al.
[25]

IV2

Martínez
et al. [26]

IV3

24

56

42

Not
reported
accurately

–

Not
reported
accurately

• English language
• Published between
1966-2002

Home monitoring using specialised devices
in conjunction with a telecommunication
systems.

• All-cause mortality
• HF admissions
• Length of stay
• Quality of life
• Acceptability
• Compliance
• Cost
• ED presentations

Observational studies suggested that telemonitoring:

• English language

Device-based technologies - 16 studies

• Published before
August 2007

Telephone touch-pads - 12 studies
Video-consultation-based studies - 3 studies
Website-based telemonitoring - 5 studies
Combined modalities - 21

• Hospitalisation
• Quality of life
• Medication
• Cost
• Length of stay

• Decreased hospitalizations (8 studies)
• Improved QOL (5 studies)
• Fewer re-hospitalizations and combined events
(1 study)
• Reduced time to target drug dosage (1 study)
• No significant changes (1 study)
• Change in mood (1 study)
• Improved QOL (1 study)
• Reduced hospital length of stay (1 study)
• Increased hospital length of stay (1 study)
• Decreased hospitalizations (7 studies)
• Reduced costs (6 studies)

• English and Spanish
language
• Published between
1951-2004

Home monitoring of HF patients using
peripheral devices for measuring and
automatically transmitting data.

• Cost
• Acceptability•
Health status
• Hospital
admissions
• Length of stay
• Quality of life
• Feasibility/viability

Compared to the control groups the evidence
suggests that telemonitoring;
• Improved quality of life (12 studies)
• Reduced length of hospitalisation (12 studies)
• Reduced mortality (4 studies)
• Reduced costs (9 studies)
• Reduced unattended emergencies (1 study)
• Equipment easy to use (5 studies)

• Reduced hospitalisation (10 studies) and
readmission rates (2 studies)
• Reduced length of stay (4 studies)
• Reduced ED presentations (2 studies)
• Reduced inpatient costs (1 study)
• Was acceptable to patients (3 studies), patients
were highly satisfied (>86%)(2 studies) and improved
quality of life (1 study).
Compared with usual care telemonitoring RCTs:
• Reduced hospitalisation (2 studies) and readmission
rates (1 study)
• Reduced mortality (1 study)
• Reduced length of stay (1 study)
• Improved quality of life and high patient satisfaction
(1 study)
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Seto [27]

III4

10

586

• English language
• Published between
inception – April 2010

Telemonitoring systems with a component
of home physiological measurements.

RCT– 6 studies, Non-randomised – 12 studies, Observational- 6 studies.
RCT- 23 Studies, Non Randomised – 10 Studies, Pre-post – 15 Studies, Feasibility – 1 Study, Unknown design – 8.
3
RCT – 13 studies, Non-randomised – 10 studies, Clinical series or descriptive studies – 19 studies.
4
RCT- 5 studies, Non-randomised - 4 studies, Survey – 1 study.
1
2

• Cost

• 9/10 studies analysed direct healthcare system
costs. 1/10 study investigated direct patient costs.
• All the studies found cost reductions from
telemonitoring compared to usual care, ranging
between 1.6% and 68.3%
• Cost reductions were predominantly attributed to
reduced hospitalisation expenditures.
• A 3.5% lower direct patient costs was identified,
related to patient travelling.
• 55% of patients were willing to pay $20 to use
telemedicine and 19% were willing to pay $40.

Purcell et al. BMC Family Practice 2014, 15:43
http://www.biomedcentral.com/1471-2296/15/43

Table 4 Summary table of included reviews – heart failure (Continued)

Page 11 of 14

Purcell et al. BMC Family Practice 2014, 15:43
http://www.biomedcentral.com/1471-2296/15/43

Page 12 of 14

reviews, fewer than six included studies reported LOS as
an outcome [8,24,25]. In these three reviews all but one
study reported reduced length of hospital stay following
the intervention [25].
The other two reviews included 12 studies each that
reported LOS as an outcome, although had conflicting
findings. The recent review published by Klersy [23]
concluded that length of stay was not different between
remote patient monitoring (combined telemonitoring
and structured telephone support) and usual care for either HF (95% CI 20.12–0.13, P = 0.88) or all-cause hospitalisation (95% CI 20.18–0.02, P = 0.83). However, the
older review by Martínez et al. [26] reported that telemonitoring reduced length of hospitalisation.
Mortality

Six reviews of HF management used all-cause mortality as
an outcome measure [8,10,21,22,24,26]. As can be seen
from Table 5, a range of interventions improved mortality.
In their comparative reviews, both Clark et al. [10] and
Inglis et al. [8] demonstrated that all-cause mortality was
more significantly reduced in studies using telemonitoring
rather than structured telephone support.
Quality of life

Six reviews of telemonitoring in HF reported quality of life
(QOL) as an outcome measure [8,10,23-26]. All of these reviews described some studies that had demonstrated
improved quality of life (Table 1). There was limited information provided about the measures used to evaluate
QOL. Only Klersy et al. [23] reported quality of life in terms
of quality adjusted life years (QALYS). This review calculated that remote patient monitoring was associated with a
gain of 0.06 QALYs – 0.02 due to reduced mortality and
0.04 due to reduced hospitalisations [23].

Cost

Two reviews of telemonitoring in HF focused on cost as
an outcome measure [23,27]. Both of these reviews concluded that telemonitoring reduced costs compared to
usual care. This reduction in costs was attributed to the
reduction in hospital admissions. Seto [27] also reported
a 3.5% saving in direct patient costs as a result of the reduced need for patients to travel to services. Additionally, Seto [27] identified that over half of patients were
willing to make a financial contribution to allow them to
use telemedicine.

Discussion
This systematic review of systematic reviews found that
the use of telemonitoring for patients with hypertension
and HF was associated with multiple benefits. The reviews of telemonitoring for hypertension demonstrated
that various telemonitoring interventions were able to
effect significant reductions in blood pressure. The reviews of telemonitoring for HF demonstrated a reduced
risk of mortality [8,10,21,22,24,26], fewer hospitalisations
[8,10,21,22,24-27], reduced health care costs [23,27] and
improved quality of life compared to usual care
[8,10,24-26]. It has been reported in two syntheses of the
effectiveness of telemonitoring across disease groups
that the evidence supporting the efficacy of telemonitoring is most favourable for HF and hypertension compared to other forms of chronic disease [29-31].
A key limitation in the included reviews is the heterogeneity of the interventions reported in included studies and
reviews [8,18,19]. Telemonitoring interventions are frequently multi-dimensional, containing a range of elements
including the transmission of physiological data, coaching,
telephone support, video-consultations, nurse interventions
and web based communications [30]. The rapid technological advancements that have been seen in the last decade

Table 5 Summary of all-cause mortality
Reference

Intervention

Results

Chaudhry
et al. [21]

Automated monitoring of signs &
symptoms

56% reduced mortality (1 study)

Clark et al.
[10]

Telemonitoring – 4 studies

20% reduction in all-cause mortality (RR 0.80, 95% CI: 0.69 to 0.92; 14 studies)

Structured telephone support – 9
studies

Decrease in all-cause mortality more pronounced with telemonitoring (RR 0.62, 95% CI: 0.45 to
0.85; 4 studies) than with structured telephone support (RR 0.85, 95% CI: 0.72 to 1.01; 9 studies)

95% CI 0.22-0.85

Telemonitoring and structured
telephone support – 1 study
Giamouzis
et al. [22]

Telemonitoring

Statistically significant reduced all-cause mortality (3 studies).

Inglis et al.
[8]

Telemonitoring (transfer of daily data)
– 11 studies

Telemonitoring reduced all-cause mortality (RR 0.66, 95% CI: 0.54–0.81; 11 studies)

Structured Telephone support – 16
studies

Structured telephone support showed a non-significant trend towards reduced all-cause
mortality (RR 0.88 95% CI: 0.76– 1.01; 15 studies)
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may also impact on the ability to compare older and newer
studies using different technology [30]. Whilst some reviews reported comparisons between the various types of
telemonitoring interventions, in others it was more difficult
to differentiate the outcomes from the various interventions. Further research needs to tease out the specific aspects of telemonitoring interventions that are essential to
improving health outcomes.
A further limitation was the lack of reporting of or use of
unvalidated outcome measures. Whilst some reviews reported the range of outcomes measures used in included
studies, others provided limited data on which to evaluate
how the various outcomes were measured.
A final limitation is that, as a systematic review of reviews, this paper only included studies that had been reported within systematic reviews. This means that some
more recent research is not included in the analysis. Whilst
this recent literature includes several papers which affirm
the value of telemonitoring [32-35], it also includes some
large trials of telemonitoring in HF and hypertension which
report negative results [36-39]. These divergent findings
highlight the need for future research to more carefully interrogate how and why telemonitoring interventions work
to improve outcomes.
Whilst the specific elements of the interventions that
underpinned the positive outcomes are not clear, it is
postulated that the benefits of telemonitoring reflect a
combination of improved implementation of and adherence to guideline therapies, early identification of complications, and a positive impact on patient psychology
[8,10]. Wotton [31] asserts that telemedicine is effective
as it facilitates integration and case-management within
chronic disease, both strategies well known to improve
guideline adherence and early intervention. Further investigation into how telemedicine can best be integrated
into existing clinical primary care to enhance casemanagement will assist in developing new models of care.
Future research exploring the impact of telemonitoring
on adherence to treatment guidelines and early identification of exacerbation, will increase our understanding of
how telemonitoring interventions improve outcomes.
The benefits of telemonitoring can also be attributed
to patient empowerment and its flow on effects [40].
Providing patients with the tools and education to monitor their own symptoms, vital signs, and fluctuating
medication needs, empowers the patient to take an active role in their own healthcare. Improved selfmanagement has long been recognised as a strategy to
enhance outcomes in chronic disease. Given that patients largely find telemonitoring acceptable and easy to
use [8,10,24,26,41-43], further research focusing on the
impact of telemonitoring on self-management and the
use of telemonitoring as a patient education tool would
inform new models of care [44].
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Conclusions
In summary, this systematic review of systematic reviews
found that telemonitoring has the potential to reduce
the burden associated with hypertension and HF in primary care. However, further well-designed research is required to facilitate our understanding of how this
intervention improves various outcomes and to allow
the essential components of a telemonitoring intervention to be identified.
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